Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival
Research output: Contribution to journal › Article › peer-review
32Scopus
citations
Fingerprint
Dive into the research topics of 'Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival'. Together they form a unique fingerprint.